CD276 promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma through the TGF-β/SMAD signaling Xiaoman ZhangCuicui XuLianghai Wang Research 24 February 2024 Pages: 81 - 90
Comparison of trastuzumab emtansine, trastuzumab deruxtecan, and disitamab vedotin in a multiresistant HER2-positive breast cancer lung metastasis model Negar PourjamalNarjes YazdiMark Barok Research Open access 17 February 2024 Pages: 91 - 102
Comparison of ex vivo bioluminescence imaging, Alu-qPCR and histology for the quantification of spontaneous lung and bone metastases in subcutaneous xenograft mouse models Marie-Therese HaiderVera FreytagTobias Lange Research Open access 14 February 2024 Pages: 103 - 115
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations Michele MaffezzoliMatteo SantoniSebastiano Buti Research Open access 16 February 2024 Pages: 117 - 129
Differentiation of benign and metastatic lymph nodes in soft tissue sarcoma Anton Burkhard-MeierVindi JurinovicLars H. Lindner Research Open access 29 February 2024 Pages: 131 - 141
Prediction of transformation in the histopathological growth pattern of colorectal liver metastases after chemotherapy using CT-based radiomics Shengcai WeiXinyi GouYi Wang Research 28 February 2024 Pages: 143 - 154
Letter: Estimating the baseline local recurrence rate for a brain metastasis after neurosurgical resection Joshua S. SuppreeSiddarth KannanRasheed Zakaria Correspondence 14 February 2024 Pages: 155 - 157